Ignite Creation Date:
2025-12-24 @ 5:21 PM
Ignite Modification Date:
2026-01-01 @ 12:20 PM
Study NCT ID:
NCT03084250
Status:
UNKNOWN
Last Update Posted:
2017-05-03
First Post:
2017-03-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Investigation of Peginterferon Alfa-2a on Optimal in Chronic Hepatitis B Patients Who Have a High Risk of HCC
Sponsor:
Shanghai Nanhui Nanhua Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-03-10
Start Date Type:
ACTUAL
Primary Completion Date:
2023-04-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-12-01
Completion Date Type:
ESTIMATED
First Submit Date:
2017-03-14
First Submit QC Date:
None
Study First Post Date:
2017-03-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-05-02
Last Update Post Date:
2017-05-03
Last Update Post Date Type:
ACTUAL